|
US2016346171A1
|
|
Oral composition and confection
|
|
JP2016136908A
|
|
Weight gain inhibitor of organism
|
|
US2016195551A1
|
|
Method for evaluating salivary adiponectin level and kit for measuring salivary adiponectin level
|
|
JP2015017051A
|
|
Metabolic syndrome therapeutic agent
|
|
JP2012097081A
|
|
Improving agent for vascular endothelial function for transdermal administration and blood sugar level reducer for transdermal administration
|
|
JP2012177670A
|
|
Method for evaluating effect of preventing wrinkle due to ultraviolet rays and skin external preparation for displaying effect of preventing wrinkle
|
|
WO2005094188A2
|
|
Method of invasiveness control and use of adiponectin
|
|
WO2005093083A1
|
|
Method of disease prediction and method of using the same
|
|
JP2005287479A
|
|
Method for extracting tissue stem cell and device using the method
|
|
JP2005287478A
|
|
Human fat precursor cell line and method for using the same
|
|
JP2005278617A
|
|
Arteriosclerosis developing type double knockout mouse and method for utilizing the same
|
